Mark Gowland
Comptroller/Controller/Auditor at FENNEC PHARMACEUTICALS INC.
Network origin in Mark Gowland first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 9 | |
Advanced Water Technologies Ltd.
 Advanced Water Technologies Ltd. Environmental ServicesIndustrial Services Advanced Water Technologies Ltd. is a British company that offers a range of water treatment services and products, including water treatment chemicals such as solid chemicals and pre-treatment chemicals. The private company was founded in 2001 and is based in Warrington, UK. It also has subsidiaries in the UK. The company's goal is to ensure that their clients are fully compliant with the latest legislation relating to water quality and water safety, making their premises 100% safe. To find out more about their services and products, customers can contact their experienced team at 01925 713273.
2
| Private Company | Environmental Services | 2 |
Certifact Services Ltd.
 Certifact Services Ltd. Water UtilitiesUtilities Part of Advanced Water Technologies Ltd., Certifact Services Ltd. provides water hygiene and water treatment services. The private company is based in Bexley, UK. The British company was founded in 2012. Certifact Services was acquired by Advanced Water Technologies Ltd. on April 28, 2023.
1
| Subsidiary | Water Utilities | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark Gowland via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| SOLIGENIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Essetifin SpA
 Essetifin SpA Pharmaceuticals: MajorHealth Technology Essetifin SpA operates as a holding company. The company was founded in 1957 and is headquartered in Rome, Italy. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| AMARILLO GOLD | Precious Metals | Director/Board Member | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Sales & Marketing | |
| DCML LLC | Founder Founder | ||
Nerviano Medical Sciences SRL
 Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Purchase Associates LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| University of Bath | College/University | Undergraduate Degree | |
| Arizona State University | College/University | Doctorate Degree | |
| Loyola University Maryland, Inc. | College/University | Undergraduate Degree | |
| University of South Carolina | College/University | Graduate Degree | |
Songbird Holdings LLC
 Songbird Holdings LLC Medical SpecialtiesHealth Technology Songbird Holdings LLC designs and manufactures hearing devices. Its products include songbird ultra, songbird ultra 2.0 replacement batteries, 2-pack ultra 2.0 right ear assembly and songbird air. The firm offers its products online, as well as through retailers. Songbird makes it as easy as buying a pair of new reading glasses. It provides a strong alternative to traditional hearing aids that can cost thousands of dollars. The company was founded in 2000 by Frederick J. Fritz and is headquartered in Tulsa, OK. | Medical Specialties | Corporate Officer/Principal | |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Pharmaceuticals: Major | President | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing | |
Mayo Clinic
 Mayo Clinic Hospital/Nursing ManagementHealth Services Mayo Clinic provides health care services. Its products and services include healthy living program, sports medicine, Mayo clinic health letter, medical products, population health and wellness programs, medical laboratory services and mayo clinic voice apps. The firm offers medical services in the areas of dermatology, allergy, hypertension, neurology, oncology, psychiatry, radiation oncology, and rheumatology. The company was founded by William J. Mayo and Charles H. Mayo in 1986 and is headquartered in Rochester, MN. | Hospital/Nursing Management | Corporate Officer/Principal | |
| University of Milan | College/University | Corporate Officer/Principal Doctorate Degree | |
| WESDOME GOLD MINES LTD. | Precious Metals | Director/Board Member | |
| University of Huddersfield | College/University | Undergraduate Degree | |
| Biogen Canada, Inc. | Corporate Officer/Principal | ||
Tecnogen SpA
 Tecnogen SpA Electrical ProductsProducer Manufacturing Tecnogen SpA provides electric generators. It also offers lighting towers. The firm has a capacity of 35000 units for the global market and has branch offices in the United Kingdom, Germany, and Singapore. The company is headquartered in Piacenza, Italy. | Electrical Products | Chief Executive Officer | |
| ARCH BIOPARTNERS INC. | Pharmaceuticals: Major | Director/Board Member | |
Accelera Srl
 Accelera Srl BiotechnologyHealth Technology Accelera SRL operates as an drug discovery development research organization. It offers discovery, development, and bioanalysis and PK services. The company is headquartered in Nerviano, Italy. | Biotechnology | Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree | |
| Sigma-Tau Research Switzerland SA | President | ||
| Prassis - Istituto di Ricerche Sigma-Tau SpA | Chief Executive Officer | ||
| Sigma Tau Rare Diseases SA | Chief Executive Officer | ||
| Gentium GmbH | Chief Operating Officer | ||
Servier IP UK Ltd.
 Servier IP UK Ltd. Medical DistributorsDistribution Services Part of Baxter International, Inc., Servier IP UK Ltd. is a private company that wholesales pharmaceutical products. Servier IP UK Ltd. is based in Slough, UK. Servier IP was acquired by Baxter International, Inc. from Essetifin SpA on July 23, 2015 for $1,255.92 million. | Medical Distributors | Chief Executive Officer | |
| John Levin & Co. | Corporate Officer/Principal | ||
Exelead, Inc.
 Exelead, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Exelead, Inc. is a biopharmaceutical contract development and manufacturing company. The private company is based in Indianapolis, IN. John Rigg has been the CEO of the company since 2014. Exelead was acquired by Merck KGaA from Leadiant Biosciences SA on February 23, 2022 for $780 million. | Pharmaceuticals: Major | Director/Board Member | |
Leadiant Biosciences SpA
 Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The private company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Pharmaceuticals: Major | Chief Executive Officer | |
| ODONATE, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Leadiant Biosciences Ltd.
 Leadiant Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences Ltd. researches, manufactures, and markets therapies for patients. The private company is based in London, UK, and has subsidiaries in Germany. The British company was founded in 1957. Antonio Gama da Silva has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member | |
PTC Therapeutics GT, Inc.
 PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Part of PTC Therapeutics, Inc., PTC Therapeutics GT, Inc. is a private company that innovates DNA therapeutics to provide long-term efficacy for patients with debilitating and fatal diseases. The company is based in Lynnfield, MA. The company was founded by Chrystyna Bedrij Stecyk. | Medical Specialties | Chief Operating Officer | |
Naicons Srl
 Naicons Srl Packaged SoftwareTechnology Services Naicons Srl develops a game-changing drug discovery platform. The private company is based in Milan, Italy. | Packaged Software | Director/Board Member Director/Board Member | |
| Alchem Investment Partners GP LLC | Corporate Officer/Principal | ||
PTC Therapeutics Ltd.
 PTC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2012, PTC Therapeutics Ltd. is a British pharmaceutical company that develops pharmaceutical products. Part of PTC Therapeutics, Inc., the private company is based in London, UK. | Pharmaceuticals: Major | Director/Board Member | |
| LAVRAS GOLD CORP. | Precious Metals | Director/Board Member |
Statistics
International
| United States | 25 |
| Italy | 11 |
| Canada | 6 |
| United Kingdom | 6 |
| Switzerland | 3 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 8 |
| Non-Energy Minerals | 5 |
| Finance | 2 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 44 |
| Corporate Officer/Principal | 33 |
| Independent Dir/Board Member | 13 |
| Chairman | 12 |
| Chief Executive Officer | 12 |
Most connected contacts
| Insiders | |
|---|---|
| Khalid Islam | 29 |
| Marco Brughera | 19 |
| Adrian Haigh | 15 |
| Chris Rallis | 14 |
| Rostislav Raykov | 11 |
| Jodi Cook | 10 |
| Shubh Goel | 6 |
| Robert Andrade | 5 |
| Peter Barratt | 2 |
| Nicola Barratt | 1 |
| Ananya Bhattacharya | 1 |
- Stock Market
- Insiders
- Mark Gowland
- Company connections